Abstract:Idiopathic cholangiopathies are diseases that affect cholangiocytes, and they have unknown etiologies. Currently, orthotopic liver transplantation is the only treatment available for end-stage liver disease. Limited access to the bile duct makes it difficult to model cholangiocyte diseases. In this study, by mimicking the embryonic development of cholangiocytes and using a robust, feeder- and serum-free protocol, we first demonstrate the generation of unique functional 3D organoids consisting of small and large cholangiocytes derived from human pluripotent stem cells (PSCs), as opposed to traditional 2D culture systems. At day 28 of differentiation, the human PSC-derived cholangiocytes expressed markers of mature cholangiocytes, such as CK7, CK19, and cystic fibrosis transmembrane conductance regulator (CFTR). Compared with the 2D culture system-generated cholangiocytes, the 3D cholangiocyte organoids (COs) showed higher expression of the region-specific markers of intrahepatic cholangiocytes YAP1 and JAG1 and extrahepatic cholangiocytes AQP1 and MUC1. Furthermore, the COs had small-large tube-like structures and functional assays revealed that they exhibited characteristics of mature cholangiocytes, such as multidrug resistance protein 1 transporter function and CFTR channel activity. In addition to the extracellular matrix supports, the epidermal growth factor receptor (EGFR)-mediated signaling regulation might be involved in this cholangiocyte maturation and differentiation. These results indicated the successful generation of intrahepatic and extrahepatic cholangiocytes by using our 3D organoid protocol. The results highlight the advantages of our 3D culture system over the 2D culture system in promoting the functional differentiation and maturation of cholangiocytes. In summary, in advance of the previous works, our study provides a possible concept of small-large cholangiocyte transdifferentiation of human PSCs under cost-effective 3D culture conditions. The study findings have implications for the development of effective cell-based therapy using COs for patients with cholangiopathies.

Human Bile Contains Cholangiocyte Organoid-Initiating Cells Which Expand as Functional Cholangiocytes in Non-canonical Wnt Stimulating Conditions

Human branching cholangiocyte organoids recapitulate functional bile duct formation

Generation of Organoids from Mouse Extrahepatic Bile Ducts

Cholangiocyte organoids can repair bile ducts after transplantation in the human liver

Cell Isolation and Organoid Culture from Mouse Liver and Small Intestine

Hydrogels derived from decellularized liver tissue support the growth and differentiation of cholangiocyte organoids

Bioengineered Tubular Biliary Organoids

3D organoid cultivation improves the maturation and functional differentiation of cholangiocytes from human pluripotent stem cells

Exploiting the plasticity of cholangiocytes to repair the biliary tree

Modeling bile duct ischemia and reoxygenation injury in human cholangiocyte organoids for screening of novel cholangio-protective agents

Extrahepatic Bile Duct Organoids as a Model to Study Ischemia/Reperfusion Injury During Liver Transplantation

Regional Differences in Human Biliary Tissues and Corresponding In Vitro –Derived Organoids

Use of human tissue stem cell-derived organoid cultures to model enterohepatic circulation

Cholangiocyte organoids to study drug-induced injury

Hepatobiliary Organoids and Their Applications for Studies of Liver Health and Disease: Are We There Yet?

The New Frontier in Regenerative Medicine for the Study and Treatment of Cholangiopathies

Organoids and Spheroids as Models for Studying Cholestatic Liver Injury and Cholangiocarcinoma

Liver organoids cocultured on decellularized native liver scaffolds as a bridging therapy improves survival from liver failure in rabbits

Liver ductal organoids reconstruct intrahepatic biliary trees in decellularized liver grafts

Generation of liver bipotential organoids with a small-molecule cocktail

Generation and metabolomic characterization of functional ductal organoids with biliary tree networks in decellularized liver scaffolds